Gilead Sciences said on Monday its experimental HIV treatment met the main goal and was found to be statistically ...

With a second late-stage trial win for its investigational HIV combo in the books, Gilead Sciences is moving full steam ahead ...

Gilead Sciences said on Monday its experimental HIV treatment was found to be statistically non-inferior to its top-selling ...

Gilead Sciences, Inc. GILD announced that the investigational single-tablet regimen of bictegravir and lenacapavir for the ...

According to the U.S. Centers for Disease Control and Prevention (CDC) and other sources, there are approximately 1.2 million ...

When you’re living with HIV, there are a few health markers that your doctor will use to keep track of your care. One of them ...

HIV treatment has significantly evolved over the past 30 years, transforming HIV from a fatal disease to a manageable chronic condition. Despite advances, challenges remain in treatment access, stigma ...

HHUKWINI - Prime Minister (PM) Mmiso Russell Dlamini receives the box of injectable Lenacapavir for PrEP, a new antiretroviral (ARV) drug, from the US Charge d’Affaires Marc Weinstock, during the ...

Much of what we know about HIV and AIDS has changed since the 1980s, but a 1989 law based on outdated science is still being ...

World AIDS Day 2025 highlights key signs and symptoms of HIV that people often miss. Knowing them early can support timely testing and care.

A federally funded clinical trial suggests knowing HIV viral load (number of HIV particles in the body) doesn’t improve the ...